Skip to content

Small Intestinal Submucosa Graft for Repair of Anterior Urethral Strictures

Small Intestinal Submucosa Graft as an Alternative to Conventional Buccal Mucosa for Substitution Urethroplasty of Anterior Urethral Strictures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06192654
Enrollment
10
Registered
2024-01-05
Start date
2023-11-10
Completion date
2025-12-30
Last updated
2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urethral Stricture, Male

Keywords

urethral stricture

Brief summary

The field of research for this study is tissue engineering and the utilization of a small intestinal submucosa graft as a substitute biomaterial for conventional buccal mucosa in substitution urethroplasty of anterior urethral strictures.

Detailed description

Urethral stricture refers to the abnormal narrowing of the urethral lumen resulting from fibrosis that affects the urethral epithelium and underlying corpus spongiosum. The management of urethral stricture longer than 2 cm a major therapeutic challenge in clinics. Currently available surgical techniques require harvesting of grafts from autologous sites. However, there are numerous disadvantages associated with autografts, such as limited availability and variable quality, donor site morbidity, increased risk of surgical complications; thereby the application of this method is especially limited for large defects. The hypothesis of this study is that the small intestinal submucosa graft can be used as an alternative biomaterial to buccal mucosa for substitution urethroplasty in urethral stricture patients. The aim of this study is to assess safety and efficacy of surgical treatment of patients with anterior urethral stricture using a small intestinal submucosa graft. The follow-up time for all patients in this study was 5 years. The follow-up regimen includes retrograde and pericatheter urethrography, voiding cystourethrography, uroflowmetry, cystoscopy, and voiding symptoms monitoring. Telephone follow-up will take place in between these assessments.

Interventions

PROCEDURESmall intestinal submucosa (SIS) graft urethroplasty

Standard technique of doing a substitution urethroplasty with no modification to the surgical steps. Instead of an autologous oral bucal mucosa graft, the small intestinal submucosa graft is sutured to the healty urethral area after incision of the urethra at the stricture location.

PROCEDUREAutologous oral bucal mucosa graft urethroplasty

Standard technique of doing a substitution urethroplasty with no modification to the surgical steps. The autologous oral bucal mucosa graft is sutured to the healty urethral area after incision of the urethra at the stricture location.

Sponsors

Xiaoyong Zeng
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients signed informed consent form * Patients with a single, longer than 2.0 cm and shorter than or equal to 7.0 cm anterior urethral stricture * Patients undergoing substitution urethroplasty for urethral stricture.

Exclusion criteria

* Patients without surgical indication * Subtotal and total urethral strictures * Radiation therapy to the abdomen or pelvis * Lichen sclerosis related strictures * Patients with previous hypospadias repair * Neurogenic urinary tract disorders * Mental disorders * Patients with a known biologic sensitivity or a cultural aversion to the use of porcine materials. * Patients with severe dysfunction of heart, lung, liver, kidney and other important organs , endocrine system and blood system. * Patient with malignant tumor * Patient who cannot be regularly examined due to any circumstances * Any clinical state which does not ensure the safe implementation of study procedure (investigator's view)

Design outcomes

Primary

MeasureTime frameDescription
Urethral patency4 weeks post-surgeryA peri-urethrogram will be performed prior to catheter removal

Secondary

MeasureTime frameDescription
Serious adverse events4 weeks post-surgeryFrequency, type and severity of serious adverse events
Voiding symptoms2 months up-to 5 years post-surgeryParticipants are filling out the International Prostate Symptom Score (IPSS) questionnaire.
Urine flow2 months up-to 5 years post-surgeryParticipants are undergoing an uroflowmetry. This test measures the volume of urine released from the body, the speed with which it is released, and how long the release takes.
Anatomic recurrence of urethral stricture observed by cystoscopy 、 Retrograde urethrography(RUG)、 Voiding cystourethrography(VCUG)Through study completion, an average of up to 5 yearsFull assessment of the urethral lumen after the surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026